UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
- J. B. Singer
- , Y. Shou
- , F. Giles
- , H. M. Kantarjian
- , Y. Hsu
- , A. S. Robeva
- , P. Rae
- , A. Weitzman
- , J. M. Meyer
- , M. Dugan
- , O. G. Ottmann
- Novartis Institutes for Biomedical Research
- Novartis Institutes for Biomedical Research
- Department of Cancer Biology
- Goethe University
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
117
Citations
(Scopus)